Stock Quote

Northfield Laboratories Inc. (NFLD.OQ) (NASDAQ Stock Exchange Global Market)
As of  --
0.00USD
Price Change
+0.00
Percent Change
+0.00%
 
$0.00
--
+0.00%
$0.00
--
0
$0.00
$0.00
$0.00
$0.00
0.00
0

Research Another Stock: Symbol Look-up
FDA Calendar Updates: AMAG Pharma Up, Northfield Labs Down
Friday, 1 May 2009 03:53am EDT(SeekingAlpha) 
Northfield Blood Substitute Rejected by FDA
Friday, 1 May 2009 12:28am EDT(TheStreet) 
12 Extreme FDA Trades on New Product Decisions
Thursday, 9 Apr 2009 03:15pm EDT(SeekingAlpha) 
Northfield, Polyheme Not Long for This World
Wednesday, 18 Mar 2009 12:21am EDT(TheStreet) 
 

Profile

Northfield Laboratories Inc. was established to research, develop, test, manufacture, market, and distribute a hemoglobin-based blood substitute product. The Company is engaged in developing a hemoglobin-based, oxygen-carrying red blood cell substitute. The initial indication the Company is seeking... Full Description

Company Address

Northfield Laboratories Inc.
1560 Sherman Avenue
Suite 1000
Evanston   IL   60201
P: +1847.8643500
F: +1847.8643577

Analyst Research

Performance of Key Competitors

Company Price Change
Biopure Corporation $0.01 -0.00
Oxygen Biotherapeutics, Inc. $5.14 -0.06
Haemonetics Corporation $53.38 +0.08
  NFLD.OQ Industry
P/E(TTM) -- 13.21
P/S(TTM) -- 32.78
ROI(TTM) -109.01 2.11
ROE(TTM) -109.07 3.33
No consensus estimates data available.
Total Revenue $0.00M
Net Income $-6.25M
EPS $-0.23